Medical Xpress·3 min read·hard
New heart disease mechanism revealed: Next-generation targeted therapy shows benefit across mutation types
C
Centro Nacional de Investigaciones Cardiovasculares
✦AI Summary
A study led by the CNIC has identified a new molecular mechanism in hypertrophic cardiomyopathy and confirmed that the drug mavacamten is effective across various genetic mutations. This provides a more targeted approach to treating the most common inherited heart disease.
by Centro Nacional de Investigaciones Cardiovasculares
healthscience
✦
Get the full story
Sign up for Headlinne to unlock AI insights, political bias analysis, and your personalized news feed.
Create free accountAlready have an account? Sign in